{"organizations": [], "uuid": "1f2be2e4e54431b6f017ce92ada55e728e521426", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-harvest-one-cannabis-says-favourab/brief-harvest-one-cannabis-says-favourable-results-from-phase-2-clinical-trials-using-satipharm-capsules-idUSASB0C3JH", "country": "US", "domain_rank": 408, "title": "BRIEF-Harvest One Cannabis Says Favourable Results From Phase 2 Clinical Trials Using Satipharm Capsules", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-01T15:54:00.000+02:00", "replies_count": 0, "uuid": "1f2be2e4e54431b6f017ce92ada55e728e521426"}, "author": "", "url": "https://www.reuters.com/article/brief-harvest-one-cannabis-says-favourab/brief-harvest-one-cannabis-says-favourable-results-from-phase-2-clinical-trials-using-satipharm-capsules-idUSASB0C3JH", "ord_in_thread": 0, "title": "BRIEF-Harvest One Cannabis Says Favourable Results From Phase 2 Clinical Trials Using Satipharm Capsules", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "cannabis inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 1, 2018 / 1:55 PM / in 10 minutes BRIEF-Harvest One Cannabis Says Favourable Results From Phase 2 Clinical Trials Using Satipharm Capsules Reuters Staff \nFeb 1 (Reuters) - Harvest One Cannabis Inc: \n* HARVEST ONE CANNABIS INC. - FAVOURABLE RESULTS FROM PHASE 2 CLINICAL TRIALS USING SATIPHARM CAPSULES \n* HARVEST ONE CANNABIS INC - IN PHASE 2 STUDY, EIGHT PATIENTS COMPLETED STUDY, WHILE TWO PATIENTS WERE DISCONTINUED DUE TO WORSENING SEIZURES Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-01T15:54:00.000+02:00", "crawled": "2018-02-01T16:09:50.014+02:00", "highlightTitle": ""}